298 related articles for article (PubMed ID: 28514897)
21. A novel strategy of spine defect repair with a degradable bioactive scaffold preloaded with adipose-derived stromal cells.
Liang H; Li X; Shimer AL; Balian G; Shen FH
Spine J; 2014 Mar; 14(3):445-54. PubMed ID: 24360747
[TBL] [Abstract][Full Text] [Related]
22. Fusion performance of low-dose recombinant human bone morphogenetic protein 2 and bone marrow-derived multipotent stromal cells in biodegradable scaffolds: a comparative study in a large animal model of anterior lumbar interbody fusion.
Abbah SA; Lam CX; Ramruttun AK; Goh JC; Wong HK
Spine (Phila Pa 1976); 2011 Oct; 36(21):1752-9. PubMed ID: 21673630
[TBL] [Abstract][Full Text] [Related]
23. Experimental posterolateral spinal fusion with porous ceramics and mesenchymal stem cells.
Cinotti G; Patti AM; Vulcano A; Della Rocca C; Polveroni G; Giannicola G; Postacchini F
J Bone Joint Surg Br; 2004 Jan; 86(1):135-42. PubMed ID: 14765881
[TBL] [Abstract][Full Text] [Related]
24. An effective delivery vehicle of demineralized bone matrix incorporated with engineered collagen-binding human bone morphogenetic protein-2 to accelerate spinal fusion at low dose.
Zhu W; Qiu Y; Sheng F; Yuan X; Xu L; Bao H; Dai J; Zhu Z
J Mater Sci Mater Med; 2017 Dec; 29(1):2. PubMed ID: 29196819
[TBL] [Abstract][Full Text] [Related]
25. Bone graft and bone graft substitutes in spine surgery: current concepts and controversies.
Grabowski G; Cornett CA
J Am Acad Orthop Surg; 2013 Jan; 21(1):51-60. PubMed ID: 23281471
[TBL] [Abstract][Full Text] [Related]
26. Allogeneic mesenchymal precursor cells (MPCs) combined with an osteoconductive scaffold to promote lumbar interbody spine fusion in an ovine model.
Wheeler DL; Fredericks DC; Dryer RF; Bae HW
Spine J; 2016 Mar; 16(3):389-99. PubMed ID: 26291397
[TBL] [Abstract][Full Text] [Related]
27. Preclinical Study of Human Bone Marrow-Derived Mesenchymal Stem Cells Using a 3-Dimensional Manufacturing Setting for Enhancing Spinal Fusion.
Cho S; Choi H; Jeong H; Kwon SY; Roh EJ; Jeong KH; Baek I; Kim BJ; Lee SH; Han I; Cha JM
Stem Cells Transl Med; 2022 Oct; 11(10):1072-1088. PubMed ID: 36180050
[TBL] [Abstract][Full Text] [Related]
28. rhBMP-6 stimulated osteoprogenitor cells enhance posterolateral spinal fusion in the New Zealand white rabbit.
Valdes M; Moore DC; Palumbo M; Lucas PR; Robertson A; Appel J; Ehrlich MG; Keeping HS
Spine J; 2007; 7(3):318-25. PubMed ID: 17482115
[TBL] [Abstract][Full Text] [Related]
29. Bone grafting and biologics for spinal fusion in the pediatric population: current understanding and future perspective.
Letchuman V; Ampie L; Choy W; DiDomenico JD; Syed HR; Buchholz AL
Neurosurg Focus; 2021 Jun; 50(6):E8. PubMed ID: 34062508
[TBL] [Abstract][Full Text] [Related]
30. An update on bone substitutes for spinal fusion.
Miyazaki M; Tsumura H; Wang JC; Alanay A
Eur Spine J; 2009 Jun; 18(6):783-99. PubMed ID: 19280232
[TBL] [Abstract][Full Text] [Related]
31. Bone graft substitutes for use in spinal fusions.
Helm GA
Clin Neurosurg; 2005; 52():250-5. PubMed ID: 16626078
[No Abstract] [Full Text] [Related]
32. Synergistic Effect of NELL-1 and an Ultra-Low Dose of BMP-2 on Spinal Fusion.
Liu L; Lam WMR; Naidu M; Yang Z; Wang M; Ren X; Hu T; Kumarsing R; Ting K; Goh JC; Wong HK
Tissue Eng Part A; 2019 Dec; 25(23-24):1677-1689. PubMed ID: 31337284
[TBL] [Abstract][Full Text] [Related]
33. NELL-1 based demineralized bone graft promotes rat spine fusion as compared to commercially available BMP-2 product.
Yuan W; James AW; Asatrian G; Shen J; Zara JN; Tian HJ; Siu RK; Zhang X; Wang JC; Dong J
J Orthop Sci; 2013 Jul; 18(4):646-57. PubMed ID: 23686083
[TBL] [Abstract][Full Text] [Related]
34. Murine spinal fusion induced by engineered mesenchymal stem cells that conditionally express bone morphogenetic protein-2.
Hasharoni A; Zilberman Y; Turgeman G; Helm GA; Liebergall M; Gazit D
J Neurosurg Spine; 2005 Jul; 3(1):47-52. PubMed ID: 16122022
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of Anterior Vertebral Interbody Fusion Using Osteogenic Mesenchymal Stem Cells Transplanted in Collagen Sponge.
Yang W; Dong Y; Hong Y; Guang Q; Chen X
Clin Spine Surg; 2016 May; 29(4):E201-7. PubMed ID: 22576723
[TBL] [Abstract][Full Text] [Related]
36. Bone graft substitute using hydroxyapatite scaffold seeded with tissue engineered autologous osteoprogenitor cells in spinal fusion: early result in a sheep model.
Tan KK; Tan GH; Shamsul BS; Chua KH; Ng MH; Ruszymah BH; Aminuddin BS; Loqman MY
Med J Malaysia; 2005 Jul; 60 Suppl C():53-8. PubMed ID: 16381285
[TBL] [Abstract][Full Text] [Related]
37. Low-intensity pulsed ultrasound enhances posterior spinal fusion implanted with mesenchymal stem cells-calcium phosphate composite without bone grafting.
Hui CF; Chan CW; Yeung HY; Lee KM; Qin L; Li G; Leung KS; Hu YY; Cheng JC
Spine (Phila Pa 1976); 2011 Jun; 36(13):1010-6. PubMed ID: 21325987
[TBL] [Abstract][Full Text] [Related]
38. [Experimental research on spine fusion induced by tissue engineered bone].
Li GH; Hou XK; Wu XF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Feb; 25(1):39-42. PubMed ID: 12905605
[TBL] [Abstract][Full Text] [Related]
39. Lumbar spinal fusion with β-TCP granules and variable Escherichia coli-derived rhBMP-2 dose.
Pelletier MH; Oliver RA; Christou C; Yu Y; Bertollo N; Irie H; Walsh WR
Spine J; 2014 Aug; 14(8):1758-68. PubMed ID: 24486479
[TBL] [Abstract][Full Text] [Related]
40. Contemporary alternatives to synthetic bone grafts for spine surgery.
Brandoff JF; Silber JS; Vaccaro AR
Am J Orthop (Belle Mead NJ); 2008 Aug; 37(8):410-4. PubMed ID: 18836599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
